Product details
Catalog number BNCB1935-500
Price for BNCB1935-500
Size / count 1x 500 µL
This monoclonal antibody is specific to estrogen receptor alpha (ER alpha) and shows minimal cross-reaction with other members of the family. ER is an important regulator of growth and differentiation in the mammary gland. Presence of ER in breast tumors indicates an increased likelihood of response to anti-estrogen (e.g. tamoxifen) therapy. It strongly stains nuclei of epithelial cells in breast carcinomas.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/1935), Biotin conjugate, 0.1mg/mL is BNCB1935-500.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/1935), Biotin conjugate, 0.1mg/mL is available in the following size(s): 1x 500 µL.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/1935), Biotin conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/1935), Biotin conjugate, 0.1mg/mL is manufactured by Biotium.
Estimated delivery time for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/1935), Biotin conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/1935), Biotin conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd0299061270361e101108/msds/bncb1935-500.pdf.
This monoclonal antibody is specific to estrogen receptor alpha (ER alpha) and shows minimal cross-reaction with other members of the family. ER is an important regulator of growth and differentiation in the mammary gland. Presence of ER in breast tumors indicates an increased likelihood of response
Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.
A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.
Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.